STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
69 hedge funds and large institutions have $96.2M invested in Stemline Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 61 → 69 (+8)
Holders
69
Holding in Top 10
–
Calls
$253K
Puts
$171K
Top Buyers
| 1 | +$2.78M | |
| 2 | +$1.58M | |
| 3 | +$1.06M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$736K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$561K |
Top Sellers
| 1 | -$6.43M | |
| 2 | -$4.98M | |
| 3 | -$1.62M | |
| 4 |
RA
Royce & Associates
New York
|
-$1.03M |
| 5 |
PA
Perceptive Advisors
New York
|
-$736K |